Publications

5600 Results

5-Year Follow Up Results of S1106: A Randomized Phase II Us Intergroup Study of R-Hcvad Vs. R-Bendamustine Followed by Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Authors
M Kamdar;H Li;R Chen;L Rimsza;M Leblanc;T Fenske;P Barr;T Phillips;JP Leonard;BS Kahl;J Friedberg;S Smith
Journal / Conference
Blood 132:1593; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Lymphoma
Study Number(s)
S1106

Subclonal Mutations of TP53 are common in untreated follicular lymphoma and are predictive of a shortened PFS when CHOP is combined 131-Iodine Tositumomab but not with rituximab: an analysis of SWOG S0016 clinical trial

Authors
WR Burack;H Li;J Spence;D Adlowitz;L Rimsza;R Braziel;C Spier;M Kaminski;JP Leonard;RI Fisher;M Leblanc;S Smith;JW Friedberg
Journal / Conference
Blood 132:919; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
Year
2018
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Statin use, site of recurrence, and survival among post-menopausal women taking bisphosphonates as adjuvant therapy for primary breast cancer (SWOG S0307)

Authors
D Kizub;J Miao;A Stopeck;P Thompson;A Paterson;M Clemons;E Dees;J Ingle;CI Falkson;W Barlow;G Hortobagyi;JR Gralow
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster, P1-17-03
Year
2018
Research Committee(s)
Breast
Study Number(s)
S0307

Bone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel

Authors
P Lara;E Mayerson;C Tangen;A Goldkorn;Marta Van Loan;M Hussain;S Gupta;J Zhang;P Twardowski;DI Quinn;N Vogelzang;IM Thompson;N Agarwal
Journal / Conference
Annals of Oncology, Vol 29, Issue suppl_8, 1; ESMO 2018 Congress (October 19-23, Munich, Germany), poster
Year
2018
Research Committee(s)
Genitourinary
Study Number(s)
S1216

2nd Cycle Remission Achievement with 7+3 is Associated with Shorter Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials

Authors
M Othus;E Estey;G Garcia-Manero;B Wood;DL Stirewalt;J Godwin;J Weick;J Anderson;F Appelbaum;H Erba;R Walter
Journal / Conference
Blood 132:3978; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333

Long-term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-adapted Approach

Authors
D Stephens;H Li;H Schoder;D Straus;C Moskowitz;M Leblanc;L Rimsza;N Bartlett;A Evens;A Lacasce;P Barr;M Knopp;E Hsi;J Leonard;B Kahl;S Smith;JW Friedberg
Journal / Conference
Blood 132:929; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
Year
2018
Research Committee(s)
Lymphoma
Study Number(s)
S0816

Potential impact of consolidation radiation therapy for advanced Hodgkin Lymphoma: a secondary modeling of SWOG S0816 with receiver operating characteristic analysis

Authors
C Ha;H Li;H Schoder;C Pinnix;E Brem;N Bartlett;A Evens;E Hsi;L Rimsza;J Leonard;BS Kahl;M Leblanc;S Smith;L Constine;JW Friedberg
Journal / Conference
Blood 132:2927; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Lymphoma
Study Number(s)
S0816

A phase II study of dasatinib and dexamethasone as primary therapy followed by hematopoietic cell transplantation for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: CALGB Study 10701 (Alliance)

Authors
M Wieduwilt;J Yin;M Wetzler;G Uy;B Powell;J Kolitz;M Liedtke;W Stock;JH Beumer;R Mattsion;A Halvorson;S Devine;RM Stone;RA Larson
Journal / Conference
Blood 132:309; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10701

Event-free Survival as a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-level Analysis of Multiple Randomized Trials (Alliance A151614)

Authors
J Yin;B Laplant;E Storrick;J Uy;G Marcucci;H Fernandez;X Sun;S Petersdorf;F Appelbaum;M Othus;RA Larson;S Stone
Journal / Conference
Blood 132:1386; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), accepted, poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S0106

Predicting Non-Fatal Toxicities with 7+3 Induction Chemotherapy in Adult Acute Myeloid Leukemia: Analysis of SWOG Trial S1203

Authors
M Othus;G Garcia-Manero;F Appelbaum;HP Erba;R Walter
Journal / Conference
Blood 132:1403; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S1203